Harrow Health, Inc. (HROW) Q1 FY26 Earnings Call

Demand is accelerating, but profitability depends on converting growth into revenue after Q1 pricing and inventory disruptions.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-05-13
Length60 minutes
EPS$-0.63
EPS consensus$-0.43
Revenue$44.2M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All HROW earnings ยท Back to HROW overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.